
Chronic kidney disease — a proven risk factor of the development and progression of lipid metabolism disorders. The basis of these disorders — an increase in blood plasma cholesterol, triglycerides, low density lipoproteins and decreased levels of high density lipoproteins, apo AI and apo AII. There has been a decrease in the activity of enzymes: lipoprotein lipase, hepatic triglyceride lipase, lecithin-cholesterol acyltransferase. The use of lipid-modifying drugs — statins, fibrates, nicotinic acid was proposed.
хронічна хвороба нирок; холестерин; тригліцериди; ліпопротеїни низької щільності; ліпопротеїни високої щільності; апоА-I; апоА-II; ліпопротеїнліпази; печінкова тригліцеринліпаза; статини; фібрати; нікотинова кислота, apo AII, chronic kidney disease; cholesterol; triglycerides; low density lipoproteins; high density lipoproteins; apo AI; apo AII; lipoprotein lipase; hepatic triglyceride lipase; statins; fibrates; nicotinic acid, cholesterol, lipoprotein lipase, apo AI, Diseases of the genitourinary system. Urology, statins, хроническая болезнь почек; холестерин; триглицериды; липопротеины низкой плотности; липопротеины высокой плотности; апоА-I; апоА-II; липопротеинлипаза; печеночная триглицеринлипаза; статины; фибраты; никотиновая кислота, hepatic triglyceride lipase, low density lipoproteins, RC870-923, high density lipoproteins, fibrates, nicotinic acid, triglycerides, chronic kidney disease
хронічна хвороба нирок; холестерин; тригліцериди; ліпопротеїни низької щільності; ліпопротеїни високої щільності; апоА-I; апоА-II; ліпопротеїнліпази; печінкова тригліцеринліпаза; статини; фібрати; нікотинова кислота, apo AII, chronic kidney disease; cholesterol; triglycerides; low density lipoproteins; high density lipoproteins; apo AI; apo AII; lipoprotein lipase; hepatic triglyceride lipase; statins; fibrates; nicotinic acid, cholesterol, lipoprotein lipase, apo AI, Diseases of the genitourinary system. Urology, statins, хроническая болезнь почек; холестерин; триглицериды; липопротеины низкой плотности; липопротеины высокой плотности; апоА-I; апоА-II; липопротеинлипаза; печеночная триглицеринлипаза; статины; фибраты; никотиновая кислота, hepatic triglyceride lipase, low density lipoproteins, RC870-923, high density lipoproteins, fibrates, nicotinic acid, triglycerides, chronic kidney disease
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 2 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
